Tumor Ki-67, ER and PR, and antibodies against estradiol and progesterone in breast cancer patients

Tumor Ki-67, ER and PR, and antibodies against estradiol and progesterone in breast cancer patients

Aim. To investigate the associations of cell proliferation marker Ki-67 in estrogen receptor (ER) and progesterone receptor (PR) positive (ER+/ PR+) and negative (ER-/PR-) tumors with the ratio of antibodies against estradiol and progesterone (IgA1-E2/IgA1-Pg) in the serum of breast cancer (BC) pati...

Full description

Saved in:
Bibliographic Details
Main Authors: A. N. Glushkov, E. G. Polenok, S. A. Mun, L. A. Gordeeva, M. V. Kostyanko, A. V. Antonov, P. V. Bayramov, N. E. Verzhbitskaya, G. I. Kolpinskiy
Format: Article
Language:Russian
Published: Kemerovo State Medical University 2023-09-01
Series:Фундаментальная и клиническая медицина
Subjects:
breast cancer
antibodies
estradiol
progesterone
estrogen receptor
progesterone receptor
ki-67
Online Access:https://fcm.kemsmu.ru/jour/article/view/750
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://fcm.kemsmu.ru/jour/article/view/750

Similar Items